Diabetes treatment is constantly progressing, with new therapeutic options appearing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions https://sachinarvi995194.wikiworldstock.com/2040018/promising_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment